Danaher Announces CFO Transition: Matthew Gugino to Replace Matthew McGrew

Danaher Corporation announced that Matthew Gugino will succeed Matthew McGrew as Chief Financial Officer effective February 28th, 2026. McGrew will continue as an Executive Vice President after the transition and retire gradually. Gugino currently serves as Group Chief Financial Officer of the Life Sciences Innovations Group and Vice President of Financial Planning & Analysis.

Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, has announced that Matthew Gugino will succeed Matthew McGrew as Chief Financial Officer (CFO) effective February 28th, 2026. Following the transition, Mr. McGrew will continue as an Executive Vice President, gradually transitioning to retirement after more than 20 years with Danaher.

Mr. McGrew, who has served as CFO since January 2019, has been instrumental in shaping Danaher's financial strategy and portfolio evolution. He played a pivotal role in acquisitions like Cytiva and the launches of Envista and Veralto as public companies, while also navigating the company through the pandemic. Danaher's President and Chief Executive Officer, Rainer Blair, expressed gratitude for Mr. McGrew's leadership and the smooth transition he will support.

Mr. Gugino, currently Group Chief Financial Officer of the Life Sciences Innovations Group and Vice President of Financial Planning & Analysis, brings extensive experience in investor relations, FP&A, M&A, and talent development. He has been with Danaher since 2013, serving in various roles, including Vice President of Investor Relations from 2014 to 2022. Prior to joining Danaher, he held positions at Barclays, Morgan Stanley, and KPMG.

Blair highlighted Mr. Gugino's broad experience and exceptional preparation for the CFO role. He noted that Mr. Gugino's contributions have been critical in shaping Danaher's financial strategy and portfolio evolution, and he anticipates that Mr. Gugino will continue to drive the company's growth into one of the world's most respected science and technology leaders.

References:
[1] https://investors.danaher.com/2025-07-22-Danaher-Announces-Transition-Plan-for-Chief-Financial-Officer
[2] https://www.marketbeat.com/instant-alerts/filing-choreo-llc-has-311-million-holdings-in-danaher-corporation-nysedhr-2025-07-24/